| Home > Articles > TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO) > MARC |
000120011 001__ 120011 000120011 005__ 20230519145543.0 000120011 0247_ $$2doi$$a10.1080/21645515.2021.1953351 000120011 0248_ $$2sideral$$a126935 000120011 037__ $$aART-2021-126935 000120011 041__ $$aeng 000120011 100__ $$aMartinón-Torres, Federico 000120011 245__ $$aTIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO) 000120011 260__ $$c2021 000120011 5060_ $$aAccess copy available to the general public$$fUnrestricted 000120011 5203_ $$aTIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts. © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 000120011 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI07-0069$$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI10-00540$$9info:eu-repo/grantAgreement/ES/ISCIII-FIS/PI16-01569$$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI19-01090 000120011 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/ 000120011 590__ $$a4.526$$b2021 000120011 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY$$b54 / 161 = 0.335$$c2021$$dQ2$$eT2 000120011 591__ $$aIMMUNOLOGY$$b86 / 163 = 0.528$$c2021$$dQ3$$eT2 000120011 592__ $$a1.073$$b2021 000120011 593__ $$aImmunology and Allergy$$c2021$$dQ1 000120011 593__ $$aPharmacology$$c2021$$dQ1 000120011 593__ $$aMedicine (miscellaneous)$$c2021$$dQ1 000120011 594__ $$a5.5$$b2021 000120011 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000120011 700__ $$aGarcía-Sastre, Adolfo 000120011 700__ $$aPollard, Andrew J. 000120011 700__ $$0(orcid)0000-0003-2993-5478$$aMartín, Carlos$$uUniversidad de Zaragoza 000120011 700__ $$aOsterhaus, Albert 000120011 700__ $$aLadhani, Shamez N. 000120011 700__ $$aRamilo, Octavio 000120011 700__ $$aGómez Rial, Jose 000120011 700__ $$aSalas, Antonio 000120011 700__ $$aBosch, F. Xavier 000120011 700__ $$aMartinón-Torres, María 000120011 700__ $$aMina, Michael J. 000120011 700__ $$aCherry, James 000120011 7102_ $$11011$$2630$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Microbiología 000120011 773__ $$g17, 11 (2021), 4299-4327$$pHum Vaccin Immunother$$tHuman Vaccines and Immunotherapeutics$$x2164-5515 000120011 8564_ $$s1110185$$uhttps://zaguan.unizar.es/record/120011/files/texto_completo.pdf$$yVersión publicada 000120011 8564_ $$s1252832$$uhttps://zaguan.unizar.es/record/120011/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000120011 909CO $$ooai:zaguan.unizar.es:120011$$particulos$$pdriver 000120011 951__ $$a2023-05-18-15:41:56 000120011 980__ $$aARTICLE
The server encountered an error while dealing with your request.
The system administrators have been alerted.
In case of doubt, please contact deposita@unizar.es.